Immunoconjugates made of an anti-EGF receptor monoclonal antibody and type 1 ribosome-inactivating proteins from Saponaria ocymoides or Vaccaria pyramidata

British Journal of Cancer

Volumn 75, Issue 6, 1997, Pages 822-828

  Di Massimo, A M ^a,b   Di Loreto, M ^a   Pacilli, A ^a   Raucci, G ^a   D'Alatri, L ^a   Mele A ^a   Bolognesi, A ^a   Polito, L ^a   Stirpe, F ^a   De Santis, R ^a  

^a Department of Biotechnology   (Romania)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Anti epidermal growth factor receptor; Immunoconjugate; Ocymoidine; Pyramidatine

Indexed keywords

ANTIBODY CONJUGATE; EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY;

ARTICLE; PRIORITY JOURNAL;

EID: 8044250274     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.147     Document Type: Article

References (24)

1. Barbieri L, Battelli MG and Stirpe F (1993) Ribosome-inactivating proteins from plants. Biochim Biophys Ada, 1154/3/4: 237-282
2. Baselga J, Norton L, Masui H, Pandiella A, Coplan K, Miller WH and Mendelsohn J (1993) Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies. J Natl Cancer Inst, 85: 1327-1333
3. Bolognesi A, Barbieri L, Abbondanza A, Falasca AI, Camicelli D, Battelli MG and Stirpe F (1990) Purification and properties of new ribosome-inactivating proteins with RNA N-glycosidase activity. Biochim Biophys Ada, 1087: 293-302
4. Bolognesi A, Olivieri F, Batlelli MG, Barbieri L, Falasca AI, Parente A, Del Vecchio Blanco F and Stirpe F (1995) Ribosome-inactivating proteins (RNA N-glycosidases) from the seeds of Saponaria ocymoides and Vaccaria pyramiJata. Ear 1 Biochem, 228: 935-940
5. Endo Y and Tsurugi K (1987) RNA N-glycosidase activity of ricin A-chain. Mechanism of action of the toxic lectin ricin on eukaryotic ribosomes. J Biol Chem, 262: 8128-8130
6. Endo Y and Tsurugi K (1988) The /V-glycosidase activity of ricin A-chain. The characteristics of the enzymatic activity of ricin A-chain with ribosomes and with rRNA. J Biol Chem, 263: 8735-8739
7. Endo Y, Huber P\V and Wool IG (1983) The ribonuclease activity of the cytotoxin a-sarcin. J Biol Chem, 258: 2662-2667
8. Ennis BW, Lippman ME and Dickson RB (1991) The EOF receptor system as a target for antitumor therapy. Cancer Invest, 9: 553-562
9. Falini B, Bolognesi A, Flenghi L, Tazzari PL, Broe MK, Stein H, Durkop H, Aversa F, Comeli P, Pizzolo G, Barbabietola G, Sabattini E, Pileri S, Martelli MF and Stirpe F (1992) Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin. Lancet, 339: 1195-1196
10. Ferrer C, Anastasi AM, Di Massimo AM, Bullo A, Di Loreto M, Raucci G, Pacilli A, Rotondaro L, Mauro S, Mêle A and De Santis R (1997) Expression and characterization of a mouse/human chimeric antibody specific for EGF receptor. J Biotechn (in press)
11. Fox SB, Smith K, Hollyer J, Greenal M, Hastrich D and Harris AL (1994) The epidermal grow th factor receptor as a prognostic marker: results of 370 patients and review of 3009 patients. Breast Cancer Res Treat, 29:41 -49
12. Frankel AE, Tagge EP and Willingham MC ( 1995) Clinical trials of targeted toxins. Cancer Biol, 6:307-317
13. Friedman PN, Chace DF, Trail PA and Siegall CB (1993) Antitumor activity of the single-chain immunotoxin BR96 sFv-PE40 against established breast and lung tumor xenografts. J Immunol, 150: 3054-3061
14. Lappi DA and Band A (1991) Mitotoxins: growth factor-targeted cytotoxic molecules. Prog Growth Factor Res, 2: 223-236
15. Laske D, Oldfield E and Youle RJ (1995) Immunotoxins for brain therapy. Fourth Int Symp Immunoloxins. South Carolina: USA.
16. Lorimer IAJ, Wikstrand CJ, Batra SK, Bigner DD and Pastan I (1995) Immunotoxins that target an oncogenic mutant epidermal growth factor receptor expressed in human tumors. Clin Cancer Res, 1: 859-864
17. Masui H, Kamrath H, Apell G, Houston LL and Mendelsohn J (1989) Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain Cancer Res, 49:3482-3488
18. Ozawa S, Ueda M, Ando N, Abe O, Minoshima S and Shimizu N (1989) Selective killing of squamous carcinoma cells by an immunotoxin that recognizes the EGF receptor. Int J Cancer, 43: 152-157
19. Stirpe F, Bailey S, Miller SP and Bodley JW (1988) Modification of ribosomal RNA by ribosome-inactivating proteins from plants. Nucleic Acids Res, 16: 1349-1357
20. Strocchi P, Barbieri L and Stirpe F (1992) Immunological properties of ribosomeinactivating proteins and of a saporin-IgG conjugate. J Immunol Methods, 155: 57-63
21. Thorpe PE, Wallace PM, Knowles PP, Reif MG, Brown ANF, Watson GJ, Blakey DC and Newell DR ( 1988) Improved antitumor effects of immunotoxins prepared with deglycosylated ricin-A-chain and hindered disulfide linkages. Cancer Res, 48: 6396-6401
22. Thrush GR, Lark LR, Clinchy BC and Vitetta ES (1996). Immunotoxins: An update. Anna Rev Immunol, 14: 49 Tosi E, Valota O, Negri D, Adobati E, Mazzoni A Meazza R, Ferrini S, Colnaghi MI and Canevari S (1995) Antitumor efficacy of an anti-epidermal growth factor receptor monoclonal antibody and its F(ab')2 fragment against high and low EGFR-expressing carcinomas in nude mice. Int J Cancer, 62: 643-650
23. Wawrzynczak EJ (1991) Systemic immunotoxin therapy of cancer: advances and prospects. Br J Cancer, 64: 624-630
24. Workman P, Baimain A, Hickman JA, McNally NJ, Mitchinson NA, Pierrepoint CG, Raymond R, Rowlatt C, Stephens TC and Wallace J (1988) UKCCCR guidelines for the welfare of animals in experimental neoplasia. Br J Cancer, 58: 109-113